Review Evolution of the cancer genome Ondrej Podlaha, Markus Riester, Subhajyoti De and Franziska Michor Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatisti

First Page		Document Content
Date: 2012-03-27 13:34:16 Oncology Carcinogenesis Anatomical pathology RTT Biotechnology Genome instability Neoplasm Somatic evolution in cancer Cancer Tumour heterogeneity O-6-methylguanine-DNA methyltransferase Oncogenomics		Review Evolution of the cancer genome Ondrej Podlaha, Markus Riester, Subhajyoti De and Franziska Michor Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatisti Add to Reading List Source URL: michorlab.dfci.harvard.edu Download Document from Source Website File Size: 1,16 MB Share Document on Facebook

	如何查看某一个时间段新上市的某个适应症的药物？（以 2011 年上市抗肿瘤药为例） 1 打开 Advanced Search 2 限定 Current Development Status，Indication-Neoplasm，Status-Launched,点击 DocID: 1t7Ug - View Document
	Microsoft Word - KCR_ICD10_CaseFindingList_7 13 2015_draft.docx DocID: 1rkGV - View Document
	Mina Bissell, Ph.D., Receives 2012 AACR Distinguished Lectureship in Breast Cancer Research May 17, 2012 PHILADELPHIA — The American Association for Cancer Research is pleased to announce that Mina J. Bissell, Ph.D., d DocID: 1r2yU - View Document
	NIH Public Access Author Manuscript Pancreas. Author manuscript; available in PMC 2011 May 3. NIH-PA Author Manuscript DocID: 1qWKo - View Document
	1 E. 7. Study Design and Statistical Issues POLICY: Every cancer genome project should state a clear rationale for its choice of sample size, in terms of the desired sensitivity to detect cancer relevant changes. The t DocID: 1qToc - View Document